These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22015656)

  • 1. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation.
    Lim WH; Seo WW; Choe W; Kang CK; Park J; Cho HJ; Kyeong S; Hur J; Yang HM; Cho HJ; Lee YS; Kim HS
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2798-805. PubMed ID: 22015656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of endothelialization and neointimal formation with stents coated with antibodies against CD34 and vascular endothelial-cadherin.
    Lee JM; Choe W; Kim BK; Seo WW; Lim WH; Kang CK; Kyeong S; Eom KD; Cho HJ; Kim YC; Hur J; Yang HM; Cho HJ; Lee YS; Kim HS
    Biomaterials; 2012 Dec; 33(35):8917-27. PubMed ID: 22981075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
    van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Novel Stent on Re-Endothelialization, Platelet Adhesion, and Neointimal Formation.
    Tang H; Wang Q; Wang X; Zhou J; Zhu M; Qiao T; Liu C; Mao C; Zhou M
    J Atheroscler Thromb; 2016; 23(1):67-80. PubMed ID: 26347048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of biofunctional stents with endothelial progenitor cell specificity for vascular re-endothelialization.
    Kang CK; Lim WH; Kyeong S; Choe WS; Kim HS; Jun BH; Lee YS
    Colloids Surf B Biointerfaces; 2013 Feb; 102():744-51. PubMed ID: 23107953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents.
    Cho HJ; Kim TY; Cho HJ; Park KW; Zhang SY; Kim JH; Kim SH; Hahn JY; Kang HJ; Park YB; Kim HS
    J Am Coll Cardiol; 2006 Jul; 48(2):366-74. PubMed ID: 16843188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents.
    Tang C; Wang G; Wu X; Li Z; Shen Y; Lee JC; Yu Q
    J Vasc Surg; 2011 Feb; 53(2):461-71. PubMed ID: 21129910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.
    Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J
    Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization.
    Kleinedler JJ; Foley JD; Orchard EA; Dugas TR
    J Control Release; 2012 Apr; 159(1):27-33. PubMed ID: 22269665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis.
    George J; Herz I; Goldstein E; Abashidze S; Deutch V; Finkelstein A; Michowitz Y; Miller H; Keren G
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):e57-60. PubMed ID: 14615392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis.
    Ribichini F; Joner M; Ferrero V; Finn AV; Crimins J; Nakazawa G; Acampado E; Kolodgie FD; Vassanelli C; Virmani R
    J Am Coll Cardiol; 2007 Jul; 50(2):176-85. PubMed ID: 17616304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of reendothelialization and neointimal formation with stents coated with antibodies against endoglin and CD34 in a porcine model.
    Cui S; Song XT; Ding C; Meng LJ; Lv SZ; Li K
    Drug Des Devel Ther; 2015; 9():2249-56. PubMed ID: 25945036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
    Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
    Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
    J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.
    Chong E; Poh KK; Liang S; Lee RC; Low A; Teo SG; Tan HC
    J Interv Cardiol; 2010 Apr; 23(2):101-8. PubMed ID: 20236214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor.
    Ma X; Hibbert B; Dhaliwal B; Seibert T; Chen YX; Zhao X; O'Brien ER
    Cardiovasc Res; 2010 May; 86(2):338-45. PubMed ID: 20167573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix.
    Granada JF; Inami S; Aboodi MS; Tellez A; Milewski K; Wallace-Bradley D; Parker S; Rowland S; Nakazawa G; Vorpahl M; Kolodgie FD; Kaluza GL; Leon MB; Virmani R
    Circ Cardiovasc Interv; 2010 Jun; 3(3):257-66. PubMed ID: 20442358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model.
    Sharif F; Hynes SO; McCullagh KJ; Ganley S; Greiser U; McHugh P; Crowley J; Barry F; O'Brien T
    Gene Ther; 2012 Mar; 19(3):321-8. PubMed ID: 21716298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.